2018 Q1 Form 10-Q Financial Statement

#000143774918008689 Filed on May 04, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $1.573M $1.282M
YoY Change 22.7% 7.01%
Cost Of Revenue $964.0K $989.0K
YoY Change -2.53% -12.63%
Gross Profit $609.0K $293.0K
YoY Change 107.85% 343.94%
Gross Profit Margin 38.72% 22.85%
Selling, General & Admin $1.475M $1.355M
YoY Change 8.86% 11.89%
% of Gross Profit 242.2% 462.46%
Research & Development $473.0K $327.0K
YoY Change 44.65% 78.69%
% of Gross Profit 77.67% 111.6%
Depreciation & Amortization $30.00K $40.00K
YoY Change -25.0% -71.43%
% of Gross Profit 4.93% 13.65%
Operating Expenses $1.948M $1.682M
YoY Change 15.81% 20.66%
Operating Profit -$1.339M -$1.389M
YoY Change -3.6% 4.67%
Interest Expense $10.00K $30.00K
YoY Change -66.67%
% of Operating Profit
Other Income/Expense, Net $7.000K $29.00K
YoY Change -75.86% -78.03%
Pretax Income -$1.330M -$1.360M
YoY Change -2.21% 13.33%
Income Tax
% Of Pretax Income
Net Earnings -$1.332M -$1.360M
YoY Change -2.06% 13.81%
Net Earnings / Revenue -84.68% -106.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$24.14K -$24.72K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.520M $10.41M
YoY Change -56.58% -10.34%
Cash & Equivalents $2.365M $5.100M
Short-Term Investments $2.150M $5.310M
Other Short-Term Assets $380.0K $350.0K
YoY Change 8.57% 20.69%
Inventory $458.0K $310.0K
Prepaid Expenses
Receivables $970.0K $850.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.325M $11.92M
YoY Change -46.95% -9.95%
LONG-TERM ASSETS
Property, Plant & Equipment $1.229M $1.013M
YoY Change 21.32% 143.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $192.0K $267.0K
YoY Change -28.09% 19.98%
Total Long-Term Assets $1.997M $2.018M
YoY Change -1.04% -69.22%
TOTAL ASSETS
Total Short-Term Assets $6.325M $11.92M
Total Long-Term Assets $1.997M $2.018M
Total Assets $8.322M $13.94M
YoY Change -40.31% -29.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $770.0K $710.0K
YoY Change 8.45% -2.74%
Accrued Expenses $350.0K $430.0K
YoY Change -18.6% -10.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.123M $1.140M
YoY Change -1.49% -5.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $580.0K $550.0K
YoY Change 5.45% -48.11%
Total Long-Term Liabilities $580.0K $550.0K
YoY Change 5.45% -48.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.123M $1.140M
Total Long-Term Liabilities $580.0K $550.0K
Total Liabilities $1.706M $1.694M
YoY Change 0.71% -25.41%
SHAREHOLDERS EQUITY
Retained Earnings -$76.95M -$70.75M
YoY Change 8.76% 8.42%
Common Stock $83.56M $83.00M
YoY Change 0.68% 0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.616M $12.25M
YoY Change
Total Liabilities & Shareholders Equity $8.322M $13.94M
YoY Change -40.31% -29.58%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$1.332M -$1.360M
YoY Change -2.06% 13.81%
Depreciation, Depletion And Amortization $30.00K $40.00K
YoY Change -25.0% -71.43%
Cash From Operating Activities -$1.080M -$1.490M
YoY Change -27.52% 96.05%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$50.00K
YoY Change 60.0% -76.19%
Acquisitions
YoY Change
Other Investing Activities $580.0K -$30.00K
YoY Change -2033.33% -100.5%
Cash From Investing Activities $500.0K -$80.00K
YoY Change -725.0% -101.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -1.080M -1.490M
Cash From Investing Activities 500.0K -80.00K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -580.0K -1.570M
YoY Change -63.06% -131.4%
FREE CASH FLOW
Cash From Operating Activities -$1.080M -$1.490M
Capital Expenditures -$80.00K -$50.00K
Free Cash Flow -$1.000M -$1.440M
YoY Change -30.56% 161.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
isr Land Acquired With Accounts Payable
LandAcquiredWithAccountsPayable
198000
CY2018Q1 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
156000
CY2018Q1 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
317000
isr Class Of Warrant Or Right Issued For Services
ClassOfWarrantOrRightIssuedForServices
250000
CY2017Q1 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
166000
isr Class Of Warrant Or Right Issued For Services Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedForServicesWeightedAverageExercisePriceOfWarrantsOrRights
0.54
isr Land Acquired With Accounts Payable
LandAcquiredWithAccountsPayable
CY2017Q1 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
161000
isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
260000
isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
161000
isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
914000
isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
488000
CY2018Q1 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
5000
CY2017Q1 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
4000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
38000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
7700
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
773000
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
630000
CY2018Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
77000
CY2017Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
75000
CY2018Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
140000
CY2017Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
138000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7647000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7591000
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83507000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83151000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
37000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
35000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
77000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
245000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
162000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3581000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2520000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
22000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
22000
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
48000
CY2018Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
CY2017Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
CY2018Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
583000
CY2017Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
561000
CY2018Q1 us-gaap Assets
Assets
8322000
CY2017Q2 us-gaap Assets
Assets
12269000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
6325000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
10291000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5932000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10139000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2365000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5100000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3567000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5039000
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.54
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2018Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
250000
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55100229
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55017419
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55100229
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55017419
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
55000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
55000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
964000
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
989000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2915000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3051000
us-gaap Depreciation
Depreciation
56000
us-gaap Depreciation
Depreciation
50000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">New Accounting Pronouncements</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> &nbsp; Revenue Recognition, replacing guidance currently codified in Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> Revenue Recognition-Overall with various SEC Staff Accounting Bulletins providing interpretive guidance. The guidance establishes a new <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> step principle-based framework in an effort to significantly enhance comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets. The standard will be effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of its fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> but early adoption is permitted starting in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company intends to adopt the new standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and expects to use the modified retrospective method. The Company has evaluated the impact of the future adoption of ASU&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div>&nbsp;on its consolidated financial statements and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently expect significant changes in the timing of revenue recognition compared to the existing methodology.&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11:</div> Inventory. The guidance requires an entity&#x2019;s management to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016. </div>Early application is permitted. The ASU became effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2017. </div>This update did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements upon adoption.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2015, </div>the FASB issued an ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> to simplify the balance sheet classification of deferred taxes. This update requires all deferred tax assets and liabilities to be reported as non-current in the consolidated balance sheets. The ASU became effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2017. </div>This update did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to have a material impact on the Company&#x2019;s consolidated financial statements upon adoption.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> Leases (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>), which will require lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases. The update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>Early adoption is permitted. The ASU will be effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> We are currently evaluating the impact of the guidance on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification of Certain Cash Receipts and Cash Payments. The update provides guidance on classification for cash receipts and payments related to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific issues. The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of implementing this update on the consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Other accounting standards that have been issued or proposed by FASB that do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require adoption until a future date are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the consolidated financial statements upon adoption. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> discuss recent pronouncements that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</div></div>
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2018Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18000
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11000
CY2018Q1 us-gaap Inventory Net
InventoryNet
458000
CY2017Q2 us-gaap Inventory Net
InventoryNet
323000
CY2018Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
395000
CY2017Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
513000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
138000
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
622000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y58D
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
783000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
825000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2610000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2632000
CY2018Q1 us-gaap Gross Profit
GrossProfit
609000
CY2017Q1 us-gaap Gross Profit
GrossProfit
293000
us-gaap Gross Profit
GrossProfit
1405000
us-gaap Gross Profit
GrossProfit
340000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
96000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-104000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
250000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
249000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-33000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-47000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-54000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-38000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-97000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
26000
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
2000
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
11000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
58000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
44000
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
121000
CY2018Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
287000
CY2017Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
191000
CY2018Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
153000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
us-gaap Investment Income Interest
InvestmentIncomeInterest
89000
CY2018Q1 us-gaap Liabilities
Liabilities
1706000
CY2017Q2 us-gaap Liabilities
Liabilities
1667000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8322000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12269000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1123000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1106000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
658000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-531000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4264000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4499000
us-gaap Net Income Loss
NetIncomeLoss
-4342000
us-gaap Net Income Loss
NetIncomeLoss
-4307000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1332000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1360000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1335000
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1363000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4350000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4315000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
136000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
1948000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1682000
us-gaap Operating Expenses
OperatingExpenses
5764000
us-gaap Operating Expenses
OperatingExpenses
4783000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1339000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1389000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4359000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4443000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
192000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
28000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
125000
CY2018Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
CY2017Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
20000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
151000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
231000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
293000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4054000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
87000
CY2018Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2017Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
8000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
8000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
382000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
271000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4943000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8876000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8645000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1229000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1054000
CY2018Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
970000
CY2017Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
726000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
327000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1174000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
649000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76946000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72604000
CY2018Q1 us-gaap Revenues
Revenues
1573000
CY2017Q1 us-gaap Revenues
Revenues
1282000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
473000
us-gaap Revenues
Revenues
4320000
us-gaap Revenues
Revenues
3391000
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
692000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
530000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1980000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1550000
us-gaap Share Based Compensation
ShareBasedCompensation
317000
us-gaap Share Based Compensation
ShareBasedCompensation
162000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1742000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
22500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
303034
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
37500
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
96432
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
114041
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
179437
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
90000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3272000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.76
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
41000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
41000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3172000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y51D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y91D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y29D
CY2018Q1 us-gaap Short Term Investments
ShortTermInvestments
2150000
CY2017Q2 us-gaap Short Term Investments
ShortTermInvestments
3039000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
82810
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6800
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
6616000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
10602000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
27000
CY2018Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
CY2017Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55100000
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55017000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55058000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55015000

Files In Submission

Name View Source Status
0001437749-18-008689-index-headers.html Edgar Link pending
0001437749-18-008689-index.html Edgar Link pending
0001437749-18-008689.txt Edgar Link pending
0001437749-18-008689-xbrl.zip Edgar Link pending
ex_111247.htm Edgar Link pending
ex_111248.htm Edgar Link pending
ex_111249.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20180331.xml Edgar Link completed
isr-20180331.xsd Edgar Link pending
isr-20180331_cal.xml Edgar Link unprocessable
isr-20180331_def.xml Edgar Link unprocessable
isr-20180331_lab.xml Edgar Link unprocessable
isr-20180331_pre.xml Edgar Link unprocessable
isr20180331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending